Please login to the form below

Not currently logged in
Email:
Password:

iPierian

This page shows the latest iPierian news and features for those working in and with pharma, biotech and healthcare.

AbbVie and C2N take tau antibody into clinic

AbbVie and C2N take tau antibody into clinic

Last year, Bristol-Myers Squibb bought into the field via a $725m deal to acquire iPierian.

Latest news

  • BMS buys Alzheimer's player iPierian in $725m deal BMS buys Alzheimer's player iPierian in $725m deal

    BMS buys Alzheimer's player iPierian in $725m deal. Takes control of several promising candidates for neurodegenerative diseases. ... BMS has paid $175m upfront for iPierian, with the potential for additional development and regulatory milestone payments

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics